REQUEST A DEMO
Total
USD $0.00
Search more companies

Verofarm AO (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Verofarm AO Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Russian Download a sample report

"Veropharm" is a leading Russian pharmaceutical producer known in Russia and abroad as one of Russia’s largest manufacturers of generic drugs (drugs that are identical to their brand name counterparts), oncological medications, and medical adhesive bandages. Today, the company's portfolio includes over 300 products used in various fields of medicine. The Company has more than 2000 skilled professionals.

Headquarters
Proezd 2-i Yuzhnoportovyi, Dom 18, Stroenie 9, Etazh 2
Moscow; Moscow; Postal Code: 115088

Contact Details: Purchase the Verofarm AO report to view the information.

Website: https://veropharm.ru/

Basic Information
Total Employees:
Purchase the Verofarm AO report to view the information.
Outstanding Shares:
Purchase the Verofarm AO report to view the information.
Registered Capital:
Purchase the Verofarm AO report to view the information.
Financial Auditors:
Purchase the Verofarm AO report to view the information.
Incorporation Date:
January 21, 1997
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Verofarm OOO
100%
Veroinfarm OOO
100%
Versiya ZAO
100%
Company Performance
Financial values in the chart are available after Verofarm AO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
33.56%
Total operating revenue
33.56%
Operating profit (EBIT)
130.71%
Net Profit (Loss) for the Period
N/A
Total assets
10.91%
Total equity
13.71%
Operating Profit Margin (ROS)
4.09%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.03%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?